IDH-wildtype GBM demonstrates alterations in epidermal growth factor receptor (EGFR), and similar to oligodendrogliomas, exhibit TERT promoter mutations (Galbraith et al., 2020). The gene discussed is TERT; the disease is oligodendroglioma.